|1.||Chen, Yongchang: 4 articles (04/2014 - 02/2012)|
|2.||Lan, Ting: 4 articles (04/2014 - 02/2012)|
|3.||Tao, Yan: 4 articles (04/2013 - 03/2010)|
|4.||Wang, Ying: 3 articles (04/2014 - 06/2012)|
|5.||Jiang, Lu: 3 articles (04/2014 - 06/2012)|
|6.||Sang, Jianrong: 3 articles (01/2013 - 02/2012)|
|7.||Wu, Min: 2 articles (04/2014 - 01/2013)|
|8.||Qian, Hai: 2 articles (04/2014 - 01/2013)|
|9.||Li, Yueying: 2 articles (04/2014 - 01/2013)|
|10.||Chen, Yong-Chang: 2 articles (04/2013 - 03/2010)|
|1.||Stomach Neoplasms (Stomach Cancer)
03/01/2010 - "These data indicate that the activation of PKG II by 8-pCPT-cGMP inhibits the proliferation of human gastric cancer cells."
01/01/2013 - "In gastric cancer cell line AGS, expression and activity of PKG II were increased by infecting the cells with adenoviral construct encoding PKG II cDNA (Ad-PKG II) and treating the cells with cGMP analogue 8-pCPT-cGMP. "
02/01/2012 - "In the gastric cancer cell line BGC-823, the expression and activity of PKG II were increased by infecting the cells with adenoviral construct encoding PKG II cDNA and treating the cells with the cGMP analogue 8-pCPT-cGMP. "
04/01/2014 - "The human gastric cancer cell line AGS, was infected with adenoviral constructs encoding cDNA of PKG II (Ad-PKG II) to increase the expression of PKG II and was treated with 8-pCPT-cGMP to activate the kinase. "
04/01/2013 - "Increasing the activity of PKG II through infection with Ad-PKG II and stimulation with 8-pCPT-cGMP significantly attenuated the aforementioned effects of the bFGF treatment, while increased PKG I activity did not inhibit the effects of bFGF treatment. "
06/01/2012 - "Increase of PKGII activity through infection with pAd-PKGII and stimulation with 8-pCPT-cGMP efficiently reversed the above changes caused by EGF. "
|4.||Osteosarcoma (Osteogenic Sarcoma)
|1.||Complementary DNA (cDNA)
|2.||C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)
|3.||Interleukin-6 (Interleukin 6)
|6.||Epidermal Growth Factor (EGF)
|7.||3- (5'- hydroxymethyl- 2'- furyl)- 1- benzylindazole (YC 1)